Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maher K Gandhi

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
The Medical Journal of Australia|April 21, 2009
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century? CommentMaher K Gandhi
Blood|March 30, 2023
Genetic susceptibility to EBV-related diseaseMaher K Gandhi
Expert Review of Anti-Infective Therapy|January 31, 2006
Epstein-Barr virus-associated lymphomasMaher K Gandhi
Clinical Medicine (London, England)|July 14, 2005
Regulation of clinical researchMaher K Gandhi
Haematologica|June 29, 2023
Expanding the bacterial origins of nodular lymphocyte-predominant Hodgkin lymphomaMaher K Gandhi, Colm Keane
Leukemia & Lymphoma|March 31, 2009
Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: are we there yet?Kimberley Jones, Maher K Gandhi
Haematologica|July 14, 2022
CD4 T cells: the complicated key to unlocking the immune environment of classical Hodgkin lymphomaMaher K Gandhi, Colm Keane
Leukemia & Lymphoma|August 29, 2015
Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?Qingyan Cui, Maher K Gandhi
Leukemia & Lymphoma|June 12, 2012
Back to basics: the complete blood cell count adds to the ability of immunohistochemistry in diffuse large B-cell lymphoma prognosisFrank Vari, Maher K Gandhi
Journal of Personalized Medicine|March 6, 2021
Targeted Treatment of Follicular LymphomaKarthik Nath, Maher K Gandhi
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
The Medical Journal of Australia|April 21, 2009
What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century? CommentMaher K Gandhi
Blood|March 30, 2023
Genetic susceptibility to EBV-related diseaseMaher K Gandhi
Expert Review of Anti-Infective Therapy|January 31, 2006
Epstein-Barr virus-associated lymphomasMaher K Gandhi
Clinical Medicine (London, England)|July 14, 2005
Regulation of clinical researchMaher K Gandhi
Haematologica|June 29, 2023
Expanding the bacterial origins of nodular lymphocyte-predominant Hodgkin lymphomaMaher K Gandhi, Colm Keane
Leukemia & Lymphoma|March 31, 2009
Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: are we there yet?Kimberley Jones, Maher K Gandhi
Haematologica|July 14, 2022
CD4 T cells: the complicated key to unlocking the immune environment of classical Hodgkin lymphomaMaher K Gandhi, Colm Keane
Leukemia & Lymphoma|August 29, 2015
Whole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?Qingyan Cui, Maher K Gandhi
Leukemia & Lymphoma|June 12, 2012
Back to basics: the complete blood cell count adds to the ability of immunohistochemistry in diffuse large B-cell lymphoma prognosisFrank Vari, Maher K Gandhi
Journal of Personalized Medicine|March 6, 2021
Targeted Treatment of Follicular LymphomaKarthik Nath, Maher K Gandhi
Pageof 12